Senior insider sale
EVP, Chief Technical Officer at BIOMARIN PHARMACEUTICAL INC — senior position signals high conviction
$996.7K
16.49K shares
What this filing means
GUYER CHARLES GREG plans to sell 16.49K shares of BIOMARIN PHARMACEUTICAL INC valued at approximately $996.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2026ACC: 0001959173-26-002210
Officer· EVP, Chief Technical Officer
Since May 2020
16.49K
Shares to sell
$996.7K
Approx. market value
16.49K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
3/15/2024
14.50KESPP Purchase
Cash
10/31/2023
133.00Restricted Stock Vesting
Compensation
5/4/2023
1.86KTotal acquired16.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2024 | Restricted Stock Vesting Compensation | 14.50K | — |
10/31/2023 | ESPP Purchase Cash | 133.00 | — |
5/4/2023 | Restricted Stock Vesting Compensation | 1.86K | — |
| Total | 16.49K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.49K
Market value
$996.7K
3/11/2026
Total
Units
16.49K
Value
$996.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/11/2026 | 16.49K | $996.7K | NASDAQ | Planned |
| Total | 16.49K | $996.7K | ||